Clinical Trial Update: Evaluation of Efficacy and Safety of the Dosage Adjustment of Aprovel® (Irbesartan) in Hypertensive Outpatients in Current Clinical Practice [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the efficacy and safety of dosage adjustments of irbesartan (Aprovel) in hypertensive outpatients in real-world practice; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Aprovel (irbesartan)

Snippet

Sponsor: Sanofi | Conditions: Hypertension | Phase 4 | Status: COMPLETED